Class information for:
Level 1: RCAS1//EBAG9//RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELLS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
28201 173 34.2 83%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
3389 1184 KIKUCHI FUJIMOTO DISEASE//HISTIOCYTIC NECROTIZING LYMPHADENITIS//RCAS1

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RCAS1 Author keyword 220 95% 43% 74
2 EBAG9 Author keyword 17 100% 5% 8
3 RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELLS Author keyword 6 100% 2% 4
4 GYNECOL INFERTIL Address 5 45% 5% 9
5 OUTPATIENT UNIT OTOLARYNGOL Address 4 75% 2% 3
6 GYNECOL OBSTET ONCOL Address 4 35% 5% 9
7 RCAS1 ANTIGEN Author keyword 3 100% 2% 3
8 RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELLS RCAS1 Author keyword 3 100% 2% 3
9 SRCAS1 Author keyword 3 100% 2% 3
10 CHAIR GYNECOL ONCOL GYNECOL NURSING Address 3 45% 3% 5

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 RCAS1 220 95% 43% 74 Search RCAS1 Search RCAS1
2 EBAG9 17 100% 5% 8 Search EBAG9 Search EBAG9
3 RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELLS 6 100% 2% 4 Search RECEPTOR+BINDING+CANCER+ANTIGEN+EXPRESSED+ON+SISO+CELLS Search RECEPTOR+BINDING+CANCER+ANTIGEN+EXPRESSED+ON+SISO+CELLS
4 RCAS1 ANTIGEN 3 100% 2% 3 Search RCAS1+ANTIGEN Search RCAS1+ANTIGEN
5 RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELLS RCAS1 3 100% 2% 3 Search RECEPTOR+BINDING+CANCER+ANTIGEN+EXPRESSED+ON+SISO+CELLS+RCAS1 Search RECEPTOR+BINDING+CANCER+ANTIGEN+EXPRESSED+ON+SISO+CELLS+RCAS1
6 SRCAS1 3 100% 2% 3 Search SRCAS1 Search SRCAS1
7 B7H4 1 50% 1% 2 Search B7H4 Search B7H4
8 EBAG9 RCAS1 1 100% 1% 2 Search EBAG9+RCAS1 Search EBAG9+RCAS1
9 MATERNAL IMMUNE TOLERANCE 1 100% 1% 2 Search MATERNAL+IMMUNE+TOLERANCE Search MATERNAL+IMMUNE+TOLERANCE
10 OXYTOCINASE 1 12% 3% 6 Search OXYTOCINASE Search OXYTOCINASE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANTIGEN RCAS1 74 81% 25% 44
2 EBAG9 RCAS1 EXPRESSION 33 100% 8% 13
3 HUMAN UTERINE 28 69% 14% 24
4 SISO CELLS 27 92% 6% 11
5 RCAS1 EXPRESSION 15 82% 5% 9
6 RCAS1 12 63% 7% 12
7 EBAG9 RCAS1 12 86% 3% 6
8 ANTIGEN 22 1 1 EXPRESSION 8 100% 3% 5
9 EBAG9 GENE 8 100% 3% 5
10 SISO CELLS RCAS1 6 100% 2% 4

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Receptor-binding cancer antigen expressed on SiSo cells (RCAS1): a novel biomarker in the diagnosis and prognosis of human neoplasia 2009 13 74 88%
RCAS1, MT, and Vimentin as Potential Markers of Tumor Microenvironment Remodeling 2010 20 39 36%
Novel therapeutic strategies to target RCAS1, which induces apoptosis via ectodomain shedding 2011 4 95 56%
Significance of RCAS1 antigen in hepatocellular, cholangiocenular and pancreatic carcinomas 2005 15 40 93%
Biology of cancer: Thermodynamic answers to some questions 2001 13 1 100%
Immunotherapy of cervical cancer as a biological dissipative structure 2011 1 8 50%
Historic discovery of natural thermodynamic cause of cancer 2012 0 19 68%
Obstetrical prevention of human cancers 2012 0 9 44%
Cancer therapy using tumor-associated antigens to reduce side effects 2009 6 108 22%
Technology based on expression microarrays, proteomic microarrays and tissue microarrays in mammalian oncogenesis research 2011 1 30 27%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 GYNECOL INFERTIL 5 45% 5.2% 9
2 OUTPATIENT UNIT OTOLARYNGOL 4 75% 1.7% 3
3 GYNECOL OBSTET ONCOL 4 35% 5.2% 9
4 CHAIR GYNECOL ONCOL GYNECOL NURSING 3 45% 2.9% 5
5 UNIT IMMUNE SURVEILLANCE 2 36% 2.3% 4
6 LUKASZCZYK ONCOL BYDGOSZCZ 1 50% 1.2% 2
7 MED ENVIRONM PREGNANCY HLTH HAZARDS UNIT 1 30% 1.7% 3
8 CHAIR GYNECOL OBSTET 1 1 25% 1.7% 3
9 TUMOR PATHOL PATHOMORPHOL 1 17% 2.3% 4
10 GYNAECOL INFERTIL 1 50% 0.6% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000092723 AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY//DECIDUA//PROGESTERONE INDUCED BLOCKING FACTOR
2 0.0000065921 CHRONIC ENDOMETRITIS//BIOMED HUMAN ONCOL SCI DIMO//ENDOMETRIAL MICROPOLYPS
3 0.0000048392 CA 19 9//CA19 9//SPAN 1
4 0.0000047787 AGAR SOLUTIONS//RADIOL SCI TECHNOL//BIAG
5 0.0000045939 FAS//FAS LIGAND//AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
6 0.0000041339 CD3 ZETA//ORAL BIOL ORAL MED//ZETA CHAIN
7 0.0000038130 HLA G//SOLUBLE HLA G//SERV RECH HEMATOIMMUNOL
8 0.0000036711 FETAL MACROPHAGES//TERMINAL VILLI//FIBRINOID
9 0.0000033618 CANC VACCINE DEV//INNOVAT CANC THER Y//PERSONALIZED PEPTIDE VACCINE
10 0.0000031161 MOTHERS BABIES//SIR QUINTON HAZELL MOL MED//OVARIAN CRH